Cannabinoid screening matters in youth psychosis evaluations
Medical workup in pediatric first psychotic presentation: real-world diagnostic utility in a large tertiary cohort.
AI Summary
This retrospective study examined the medical evaluation of 235 children and adolescents aged 5–18 presenting with a first psychotic episode at a tertiary medical center. Urine toxicology found substance-related results in 19 patients (8.1%), predominantly involving cannabinoids. These findings highlight the practical value of toxicology screening when young people develop psychotic symptoms, although a positive result does not by itself prove that cannabis caused the episode.
Routine laboratory tests did not otherwise identify an underlying medical cause. Neuroimaging produced clinically explanatory findings in 3 patients (1.3%), and these patients had neurological abnormalities or atypical features; EEG did not identify the cause of psychosis in any case. The authors therefore support a selective, clinically guided workup, with toxicology testing and further neurological investigations based on the individual’s symptoms rather than extensive routine testing for every patient.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Brain blood-flow reductions in acute anorexia follow a cortical hierarchy
CBD showed limited adaptive-functioning differences versus placebo in boys…
Resilience linked to depression outcomes and THC positivity
Explore More Research
Stay informed about the latest cannabis science.